What kind of interaction is it?

Caution: an interaction that may reduce efficacy or raise side-effect risk and warrants monitoring.

Is this interaction backed by published research?

Yes. NutriStack lists 3 citation rows for the Fenugreek + Pramlintide pair, each linking to PubMed by PMID where available. Full sourcing methodology at https://nutristackapp.com/methodology/interactions.

Supplement × Prescription·a caution·Moderate evidence

Fenugreek + Pramlintide

Q: Can I take Fenugreek and Pramlintide together?

Possibly, but with caution. Fenugreek and Pramlintide have a documented caution-tier interaction. Fenugreek seed fiber and constituents may lower fasting or post-meal glucose in diabetes studies. Pramlintide is used with mealtime insulin and carries a boxed warning for severe hypoglycemia, particularly in type 1 diabetes. Adding or stopping Fenugreek can change post-meal glucose patterns and hypoglycemia risk during pramlintide-insulin therapy. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.

Q: How does this affect a NutriStack Stack Score?

-5 to your Stack Score per scored caution row.

Caution Moderate evidence

Fenugreek seed fiber and constituents may lower fasting or post-meal glucose in diabetes studies. Pramlintide is used with mealtime insulin and carries a boxed warning for severe hypoglycemia, particularly in type 1 diabetes. Adding or stopping Fenugreek can change post-meal glucose patterns and hypoglycemia risk during pramlintide-insulin therapy. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.

Supplement × Prescription

Open the interaction checker → Read the methodology

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances

Fenugreek and Pramlintide

Pair type

Caution

Evidence

Moderate

Source citations

Scope

Supplement × Prescription

Last verified

June 1, 2026

CautionModerate evidence

What is happening. Fenugreek seed fiber and constituents may lower fasting or post-meal glucose in diabetes studies. Pramlintide is used with mealtime insulin and carries a boxed warning for severe hypoglycemia, particularly in type 1 diabetes. Adding or stopping Fenugreek can change post-meal glucose patterns and hypoglycemia risk during pramlintide-insulin therapy. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.

Mechanism. Pramlintide slows gastric emptying, suppresses post-meal glucagon secretion, and promotes satiety, while mealtime insulin lowers glucose directly. Fenugreek seed fiber and constituents may lower fasting or post-meal glucose in diabetes studies. The overlap is pharmacodynamic rather than a known direct drug-level interaction.

Recommendation. Do not start, stop, or substantially change Fenugreek while using pramlintide with mealtime insulin without diabetes-clinician awareness. Follow the prescribed glucose-monitoring plan, keep fast-acting carbohydrate available, and review recurrent lows promptly, especially within 3 hours after Symlin injection. Pramlintide and insulin adjustments should be clinician-directed. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.

Stack Score

How it moves the number.

Effect on the composite score

If both Fenugreek and Pramlintide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1Gong J, Fang K, Dong H, Wang D, Hu M, Lu F. Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis. J Ethnopharmacol. 2016;194:260-268.Source linkedPMID
2Kim J, Noh W, Kim A, Choi Y, Kim YS. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Mol Sci. 2023;24(18):13999.Source linkedPMID
3SYMLINPEN (pramlintide acetate) injection prescribing information. DailyMed label revised 12/2019. Boxed warning and drug-interaction sections address severe hypoglycemia with insulin, slowed gastric emptying, oral-medication timing, GI motility drugs, and drugs affecting glucose metabolism. Accessed 2026-06-01.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

Open the interaction checker → Browse the research index